These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8951506)

  • 1. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of peripheral blood and synovial fluid mononuclear cells in rheumatoid arthritis.
    Dimitrijevic M; Bartlett RR
    Inflamm Res; 1996 Nov; 45(11):550-6. PubMed ID: 8951506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide, a novel immunomodulating drug, inhibits homotypic adhesion of mononuclear cells in rheumatoid arthritis.
    Dimitrijevic M; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3086-7. PubMed ID: 8962195
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of neutrophil migration soon after initiation of treatment with leflunomide or methotrexate in patients with rheumatoid arthritis: findings in a prospective, randomized, double-blind clinical trial in fifteen patients.
    Kraan MC; de Koster BM; Elferink JG; Post WJ; Breedveld FC; Tak PP
    Arthritis Rheum; 2000 Jul; 43(7):1488-95. PubMed ID: 10902750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation by interleukin-7 of mononuclear cells in peripheral blood, synovial fluid and synovial tissue from patients with rheumatoid arthritis.
    Natsumeda M; Nishiya K; Ota Z
    Acta Med Okayama; 1993 Dec; 47(6):391-7. PubMed ID: 8128913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis.
    Kraan MC; Smeets TJ; van Loon MJ; Breedveld FC; Dijkmans BA; Tak PP
    Ann Rheum Dis; 2004 Sep; 63(9):1056-61. PubMed ID: 15115713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of inflammation and metalloproteinase expression in synovial tissue by leflunomide and methotrexate in patients with active rheumatoid arthritis. Findings in a prospective, randomized, double-blind, parallel-design clinical trial in thirty-nine patients at two centers.
    Kraan MC; Reece RJ; Barg EC; Smeets TJ; Farnell J; Rosenburg R; Veale DJ; Breedveld FC; Emery P; Tak PP
    Arthritis Rheum; 2000 Aug; 43(8):1820-30. PubMed ID: 10943872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis.
    Chan V; Charles BG; Tett SE
    Br J Clin Pharmacol; 2005 Sep; 60(3):257-64. PubMed ID: 16120064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A inhibits CD69 expression induced on synovial fluid and peripheral blood lymphocytes by interleukin 15.
    Ortiz AM; García-Vicuña R; Sancho D; Laffon A; Sánchez-Madrid F; González-Alvaro I
    J Rheumatol; 2000 Oct; 27(10):2329-38. PubMed ID: 11036825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells.
    Hernández-García C; Fernández-Gutiérrez B; Morado IC; Bañares AA; Jover JA
    Arthritis Rheum; 1996 Aug; 39(8):1277-86. PubMed ID: 8702434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients.
    Cutolo M; Montagna P; Brizzolara R; Sulli A; Seriolo B; Villaggio B; Triolo P; Clerico P; Soldano S
    J Autoimmun; 2009; 32(3-4):254-60. PubMed ID: 19324522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood and synovial fluid monocyte expression of interleukin 1 alpha and 1 beta during active rheumatoid arthritis.
    Chikanza IC; Kingsley G; Panayi GS
    J Rheumatol; 1995 Apr; 22(4):600-6. PubMed ID: 7540690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increase in adhesion molecules on CD4+ cells and CD4+ cell subsets in synovial fluid from patients with rheumatoid arthritis.
    Ueki Y; Eguchi K; Shimada H; Nakashima M; Ida H; Miyake S; Nagataki S; Tominaga Y
    J Rheumatol; 1994 Jun; 21(6):1003-10. PubMed ID: 7932407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
    Cao WW; Kao PN; Chao AC; Gardner P; Ng J; Morris RE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1016-30. PubMed ID: 8719445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A; Jarvis B
    Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of soluble ICAM-1 by mononuclear cells from patients with rheumatoid arthritis patients.
    Shingu M; Hashimoto M; Nobunaga M; Isayama T; Yasutake C; Naono T
    Inflammation; 1994 Feb; 18(1):23-34. PubMed ID: 7911453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLA family in rheumatoid arthritis: evidence for in vivo regulated adhesion of synovial fluid T cells to fibronectin through VLA-5 integrin.
    García-Vicuña R; Humbría A; Postigo AA; López-Elzaurdia C; de Landázuri MO; Sánchez-Madrid F; Laffón A
    Clin Exp Immunol; 1992 Jun; 88(3):435-41. PubMed ID: 1376652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide: mode of action in the treatment of rheumatoid arthritis.
    Breedveld FC; Dayer JM
    Ann Rheum Dis; 2000 Nov; 59(11):841-9. PubMed ID: 11053058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of the effect of rheumatoid synovial fluid on proliferation and IL-2 production by total mononuclear cells and purified CD4+ cells of synovial fluid and peripheral blood.
    Hovdenes J; Hovdenes AB; Egeland T; Kvien TK; Mellbye OJ
    Scand J Rheumatol; 1990; 19(6):398-406. PubMed ID: 2259896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).
    Postigo AA; Garcia-Vicuña R; Diaz-Gonzalez F; Arroyo AG; De Landázuri MO; Chi-Rosso G; Lobb RR; Laffon A; Sánchez-Madrid F
    J Clin Invest; 1992 May; 89(5):1445-52. PubMed ID: 1373738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
    Goldenberg MM
    Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.